• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
GYN

Diagnosing Vaginitis – Why the Office Visit Still Matters

image_pdfFavoriteLoadingFavorite

CLINICAL ACTIONS:

A patient presents with vaginal inflammation with discharge, pain and/or itching. Next steps should include

Problem-focused history

  • BV
    • Fishy odor | Thin homogeneous discharge (possibly worse after intercourse)
  • Candidiasis
    • No odor | White, thick, ‘curdlike’ or ‘cheesy’ discharge | Itching and/or burning
  • Trichomoniasis
    • Foul odor | Green or yellow, frothy discharge | Vaginal pain or soreness
  • Atrophic vaginitis
    • Thin, clear discharge | Dryness | Dyspareunia | Itching
  • Irritant/allergic vaginitis
    • Burning and/or soreness
  • Desquamative Inflammatory vaginitis
    • Green or yellow (purulent) discharge | Burning | Dyspareunia

Exam including inspection of the vulva, vagina and cervix

  • BV
    • Inflammation not usually present
  • Candidiasis
    • Erythema | Edema
  • Trichomoniasis
    • Inflammation | Strawberry Cervix
  • Atrophic vaginitis
    • Inflammation | Thin/friable mucosa
  • Irritant/allergic vaginitis
    • Erythema
  • Desquamative Inflammatory vaginitis (DIV)
    • Varying vestibular and vaginal erythema

Appropriate laboratory testing

  • Collection of and microscopic examination of a 10% KOH and saline prep (wet mount), pH testing and ‘whiff test’ constitute the office-based clinical testing of samples
  • Culture (if necessary)
    • Yeast: Obtain if recurrent candidiasis or possible non-albicans Candida (suspect if blastospores ‘only’ or persistent treatment after treatment) | Negative microscopy with signs and/or symptoms of candidiasis
    • Trichomoniasis: ACOG recommends culture with a negative wet mount in the following circumstances
      • Persistent symptoms following treatment | high vaginal pH and WBCs on microscopy | Pap suspicious for T. vaginalis | patient desire for screening
      •  Note: CDC considers NAAT screening more sensitive for T. vaginalis then culture (previous gold standard) or wet mount
    • Mucopurulent cervicitis: Test (DNA or cultures) for gonorrhea or chlamydia
    • HSV: If any vulvar fissure/lesion suggestive of herpes simplex virus, perform viral culture or PCR assay for HSV DNA by swabbing the lesion
      • Type-specific HSV serologic assays might be useful in the following scenarios: 1) recurrent genital symptoms or atypical symptoms with negative HSV PCR or culture; 2) clinical diagnosis of genital herpes without laboratory confirmation (CDC STD Guidelines)

Perform “whiff test” with 10% KOH, and microscopy with saline

  • Positive whiff test
    • Negative (-) for WBC: Treat for bacterial vaginosis (BV)
    • Positive (+) for WBC: Review signs/symptoms for trichomoniasis or mixed bacterial vaginosis or cervicitis
  • Negative whiff test
    • negative (-) for WBC: Noninfectious

Determine vaginal pH

If pH is normal (<4.7) consider the following

  • Infectious: Vulvovaginal candidiasis | Genital herpes
  • Noninfectious: Physiologic leukorrhea | Vulvodynia | Dermatitis/dermatoses

If pH is elevated (>4.7) consider the following

  • Infectious: Bacterial vaginosis | Trichomoniasis | Cervicitis
  • Noninfectious: Blood | Semen | Atrophic vaginitis | Lichen planus | Desquamative inflammatory vaginitis (DIV)

SYNOPSIS:

Vaginitis is a general term for disorders of the vagina, but does not indicate the underlying cause.  Vaginitis may result from infection, inflammation, or may reflect changes in the normal vaginal microbiome.  The disorder is termed vulvovaginosis when the vulva is involved. When patients present with symptoms of itching/burning/irritation/dyspareunia/discharge consider a broad range of possibilities including but not limited to the triad of bacterial vaginosis (BV), trichomoniasis and vulvovaginal candidiasis.  Office based tests such as those above also have a low sensitivity. Accurate diagnosis may require a combination of a careful history, vulvar or vaginal biopsy and appropriate culture.

KEY POINTS:

  • Self-diagnosis and treatment, while convenient, may be unreliable and results in frequent misuse of OTC products
  • FDA approved commercial tests for BV
    • ACOG acknowledges that direct DNA probe assays for G vaginalis or chromogenic point-of-care assays for sialidase activity have acceptable performance vs Amsel criteria and Nugent scoring
    • However, because these tests only pick up one organism (i.e., G vaginalis) “the diagnostic utility of a test that identifies only a single organism (eg G vaginalis) is still being investigated and is not currently supported”
  • No microscope
    • Vaginal pH testing narrows the differential diagnosis of vaginitis for BV and trichomoniasis
    • Candidiasis: History | Exam | Culture
    • Obtain vaginal secretions slide for future Gram stain if possible
  • Incidental findings on Pap test
    • Not diagnostic
    • BV on Pap
      • Symptomatic: pH, amine test, and wet mount
      • Asymptomatic: Do not treat
    • Trichomoniasis on Pap
      • High false-positive rate (8% standard and 4% liquid-based)
        • Wet mount for confirmation
        • If wet mount negative, NAAT or culture
        • If diagnostic tests not available, can consider metronidazole, but high rate of unnecessary treatment

Want to be notified when new guidelines are released? Get ObGFirst!

Try it Free  »


Learn More – Primary Sources:

ACOG Practice Bulletin 215: Vaginitis in Nonpregnant Patients 

Vaginitis: Diagnosis and Treatment

Advances in Diagnosing Vaginitis: Development of a New Algorithm

CDC: Genital HSV Infections

Want to be notified when new guidelines are released? Get ObGFirst!

Try it Free  »

image_pdfFavoriteLoadingFavorite

< Previous
All GYN Posts
Next >

Related ObG Topics:

Trichomoniasis: CDC Diagnosis and Treatment Guidelines
Bacterial Vaginosis – CDC Diagnosis and Treatment Recommendations
Chlamydia: CDC Recommendations for Diagnosis and Treatment
Evaluating Vulvodynia – Making the Diagnosis and Key Management Points
Desquamative Vaginitis—How to Recognize and Treat It
Diagnosis and Treatment of Vulvovaginal Candidiasis
Practical info for your gynecology practice

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site